Let's get started

Make an Appointment
Find a Location
Find a Doctor
World-class experts. Close to you.

Many treatments and services are available at locations across NY and NJ.

Get care from the comfort of your home with telemedicine from MSK.

Explore MSK’s clinical trials

Our doctors and scientists work together so patients get access to cutting-edge treatments as soon as they are available.

Find a trial

Cancer news & discoveries
Trastuzumab Deruxtecan (T-DXd) for Treating HER2-Low Breast Cancer Shows Promise
FDA Approves First Targeted Drug to Treat HER2 Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug trastuzumab deruxtecan (T-DXd) was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
Read more
2021 annual report cover
Annual Report: Bold Discovery. Life-Changing Care.
Our three pillars — patient care, scientific research, and education — supported extraordinary progress last year. Read more about our most promising developments in 2021.
Read more
Cancer Straight Talk Podcast from MSK
Podcast | Cancer Straight Talk
Finding Hope and Acceptance in a Cancer Diagnosis: One Couple’s Advice
You’ve received a cancer diagnosis. Now what? For George Kolasa, it was obvious: use his glioblastoma diagnosis for good. “I’ve been chosen,” he says.
Listen to the podcast